当前位置: 首页 > 期刊 > 《健康必读·中旬刊》 > 20116
编号:13767380
溶栓与脑保护结合治疗急性脑梗死研究进展(3)
http://www.100md.com 2011年6月1日 《健康必读·中旬刊》 20116
     [7]肖小华,黄如训.缺血半暗带的研究进展.国外医学脑血管疾病分册,1999,7(5):265-268

    [8]余昌胤,等.磁共振在溶栓治疗中的应用.国外医学.老年医学分册,2001,22(5):203-205

    [9] Baird AE, Beufield A, Schlang G et al.Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol, 1997:41:581-589

    [10] Tong DC,Yanori MA, Albers GM, et al. Correlation of perfusion- and diffusion- weighted MRI with NIHSS score in acute (<6.5h) ischemic stroke. Neurology, 998, 50:846-870
, 百拇医药
    [11] Van Lookeren Campagne M,VerheulHB, Vermeulen JP, et al. Developmental changes in NMDA-indced cell swelling and its transition to necrosis with IH magnetic resonance, impedance and histology. Brain Res Dev Brain Res,1996,93:109-119

    [12] Barber BA, Darby DG, Desmond PM et al. Predication of stroke outcome with echoplanar perfusion-and diffusion-weighted MRI. Neurology, 1998,51:418-426

    [13] Kidwell CS, Saver JL, Mattielloj et al. Thrombolytic reversal of acute human cerebral ischemic injury demonstrated by diffusion/ perfusion magnetic resonance imaging. Neurology, 199:52(supple 2)A:536(Abstract)
, 百拇医药
    [14] Marks MP, Tong DC, Beaulieu C etal.Evaluation of early reperfusion and iv r-tpa therapy using diffusion and perfusion weighted MRI.Neurology, 1999, 52:1792-1798

    [15] Baird AE, Schlang G, Siewert B et al. Magnetic resonance perfusion-diffusion mismatch in acute human stroke: relation to ischemic lesion enlargement. Stroke, 1997,28:242

    [16] Marks MP, Decrespigny A, Lentz et al. Acute and chronic stroke: navigated spin_echo diffusion-weighted MR imaging Radiology, 1996,199:403-408
, 百拇医药
    [17] Jansen O, Schelling P, Fiebach J et al. Early recanalisation in acute ischemic stroke saves tissue at risk defined by MRI. Lancet, 1999, 353: 2036-2037

    [18] Caplan LK, Mohr JP, Kisther JP, et al. Should thrombolytic therapy be the first- line treatment for acute ischemic stroke? Thrombolysis: not a panacea for ischemic stroke.N Engl J Med, 1997, 337:1309-1310

    [19]黄如训,苏镇培著,脑卒中.北京:人民卫生出版社,2002:289
, http://www.100md.com
    [20]李文,包仕尧.2002年缺血性脑卒中研究进展.临床神经病学杂志,2003,16(4):253-254

    [21]董为伟.缺血性脑卒中的神经保护治疗.中华神经科杂志,2001,34(5):261-263

    [22] Yang Y, LiQ, Shuaib S. Enhanced neuro- protection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate[J] .Neuropharmacology,2000,39(5):881-888

    [23] Shuaib A, Yang Y, LiQ. Evaluating the efficacy of citicoline in embolic ischemia stroke in rats : neuroprotective effects, when used alone or in combination with urokinase [J] Exp Neurol,2000,161(2):733-739
, 百拇医药
    [24] Anderson M ,Overgaard K, Meden P, de alEffects of citicoline combined with thrombolytic therapy in a rat embolic stroke model [J] .Stroke, 1999,30(7):1464-1471

    [25] Sereghy T, Overgarrd K, Boysen G. Neuroprotection by cxcitatory amino acid antagonist angments the benefit of thrombolysis in embolic stroke in rats[J]. Stroke, 1993, 24(11):1702-1708

    [26]李颖等,溶栓合剂超早期静脉应用治疗急性脑梗死的实验研究.中风与神经疾病杂志,2003,20(4):364-365

    [27] Bednar MM, Mcauliffe T, Raumond SJ, et al. Tissue plasmingenactivatorreduce brain injure in rabbit model of thromboembolic stroke [J]. Stroke, 1990, 21(12):1705-1709

    [28]谭盛,黄如训.一种适合溶栓的脑梗塞模型[J]第一军医大学学报,1998,18(2):150-151, http://www.100md.com(胡艳雪 范永新)
上一页1 2 3